Eurosets has been selected as a finalist in the Innovation category of the BtoB Awards 2025, a recognition that celebrates the entrepreneurial excellence of the region and the companies that stand out for their vision, research, and ability to transform advanced ideas into tangible solutions.
This nomination highlights the company’s ongoing commitment to technological advancement, supported by strategic investments in new solutions for cardiopulmonary and respiratory care, the expansion of production areas, and the continuous evolution of its biomedical platforms. Today, Eurosets counts more than 450 employees and exports 87% of its production, confirming both its international footprint and its leading role within Italy’s biomedical valley.
With over 50 active patents and an investment plan of more than €27 million between 2023 and 2027, the company continues to strengthen its innovation capabilities, focusing on research, process sustainability, and high-quality “Made in Italy” engineering.
Being named a finalist at the BtoB Awards is an important acknowledgment of the daily commitment of our team and of our drive to bring to market solutions that improve patient care and support clinical centers worldwide.
The awards ceremony will take place in the coming weeks — a milestone we proudly share and one that reinforces our dedication to continuous innovation.
Click here to vote: https://btobawards.it/modena/innovazione/